Navigation Links
Cleveland Clinic Launches Fully Dedicated International Comprehensive Critical Care Program
Date:8/21/2008

Full-Scale Mobile Intensive Care Unit to Provide Patients Cleveland Clinic

Expertise Anywhere in the World

CLEVELAND, Aug. 21 /PRNewswire/ -- Cleveland Clinic has launched a comprehensive critical care program that provides specialized care by Cleveland Clinic physicians, nurse practitioners and critical care nurses to domestic and international patients through means of mobile intensive care unit, helicopter and fixed-wing jets.

With the launch of this program, Cleveland Clinic can now provide specialized critical care services to an expanded population, allowing patients access to superior medical care from bedside to bedside, no matter their location. Each mission is staffed with tremendous flexibility, dictated by the special needs of each patient.

"Cleveland Clinic continues to put patients first. This expansion allows the initiation of Cleveland Clinic care upon the arrival of our teams and ensures the highest quality of service world wide," said Marc Harrison, M.D., Director of Medical Operations and Associate Chief of Staff, Cleveland Clinic. "While in the air, our team has the full complement of Cleveland Clinic expertise at its disposal via direct communication with the Clinic or back to the referring physician. We provide a seamless transition of care and on-scene initiation of Cleveland Clinic treatment."

The program will offer uninterrupted service for patients via a diverse fleet of vehicles including ground ambulance, helicopter, and two fixed-winged jets. The jets are outfitted to provide comprehensive intensive care during intercontinental transports.

The jets are configurable for virtually every critical care scenario including mechanical ventilation, balloon pump and ECMO. This provides Cleveland Clinic the flexibility of transporting a wide variety of cases from a premature infant to an adult on a heart lung machine. The clinical expertise of the team, coupled with the technology, mak
'/>"/>

SOURCE Cleveland Clinic
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office
2. For the 14th Year in a Row, Cleveland Clinic Heart Center Is Ranked No. 1 in U.S. News & World Report Americas Best Hospitals Survey
3. Cleveland Clinic Physicians to Present at Medical Conference in Panama, July 11-12
4. NBA All-Star and Olympic Athlete LeBron James and Dr. Ian Smith Celebrate the Launch of The 50 Million Pound Challenges First Citywide Team Challenge, Kicking off in Cleveland, Ohio
5. Statement from Cleveland Clinic Regarding Pope Shenouda
6. Premier conference on neurotechnology and deep brain stimulation to be held in Cleveland June 16-18
7. Cleveland Clinic Lerner College of Medicine to Offer Full Tuition Scholarships for All Students
8. Medical Device Innovators to Discuss Next Generation of Implants at Cleveland Conference
9. HHS, Cleveland Clinic Collaborate to Advance Treatment for Neurological Disorders
10. Versus Technology, Inc. Announces Collaboration with Cleveland Clinic to Create Clinical Patient Flow Model
11. Cleveland Area Homewatch CareGivers Unveil New Alzheimers Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...discharged from hospitals on ventilator support an...ths later. Researchers from the Frances Payne Bol...ersity report these findings in American Journal ... only important outcome for patients," says Barbar...utes of Health-funded study, "Composite Outcomes o...
(Date:12/3/2009)...nd other healthcare professionals specialising in ...rt advice to guide them through the complex clinic...demic. , The paper, published online by the Am...m to stay alert to the significant concerns that s...ibly even bird flu (H5N1), to develop into a strai...
(Date:12/3/2009)...ected volunteers from virus linked to cervical can...s) -- The human papillomavirus (HPV) vaccine Cerva...six years, new research has found. , The vaccin...HPV-18) most commonly associated with cervical can...ed 15 to 25, with a normal cervical profile and no...
(Date:12/3/2009)...sive users also feel depressed or anxious when not...News) -- A survey of Chinese adolescents found tha... as likely to harm themselves as other teens. ,...ere living in the Chinese city of Guangzhou in Gua...ey had harmed themselves in some way within the pr...
(Date:12/3/2009)... The Arthritis Foundation bestowed it...ecipients during its national meeting in Atlanta. ...9 -- The Arthritis Foundation bestowed its highest... during its national meeting on Nov. 20 in Atlanta...rding Award for Distinguished Service ,The Arthrit...
Breaking Medicine News(10 mins):Health News:CWRU researchers report poor outcomes for CCI patients leaving hospitals on ventilators 2Health News:Transplant infectious disease experts provide pandemic guidance 2Health News:Transplant infectious disease experts provide pandemic guidance 3Health News:Cervarix Proves Effective Against HPV for Over 6 Years 2Health News:Teen Internet Addicts More Likely to Self-Harm: Study 2Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4
... Increases Serum Sodium Levels Through Increase in...J., May 21 Otsuka Pharmaceutical Co., Ltd. (OPC) ...alization, Inc. (OPDC) announced today that the U....nts with clinically significant hypervolemic and e...
...la Join effort to Link Services, Caseworkers , , ...n,s Policy, Practice and Research at the Universi...th Montgomery County, Pa., Stewards of Change, Mic...eaking interoperable, real-time technology system ...
...g and Financing Offerings Help Healthcare Provider...bursement Deadlines , , PLANO, Texas, May 21 Pe...tsystems.com ) today announced the availability o...cause of the American Recovery and Reinvestment Ac...
...., May 21: Managed Health Care Associates, Inc. (M... is pleased to announce that Kimberly Binaso-Stwal...American Society of Health-System Pharmacists (ASH...esignated Fellows of ASHP, will be honored during ...
...By combining the expertise of its management liabi...as developed enhanced management liability coverag...hcare organizations, including hospitals, long ter...icy and protects healthcare organizations against ...
...This year 28 students in 17 states have won awards... by the Centers for Disease Control and Prevention... the contest invites fifth- and sixth-grade studen... of the winning posters are at www.fightthebitec...
Other Medicine News:Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 2Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 3Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 4Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 5Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 6Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 7Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 8Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 9Health News:University of Pennsylvania, Montgomery County Partner on Integrated, Interoperable System Design for Child Welfare 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 3Health News:MHA Clinical Director Kimberly Binaso, Pharm.D. Awarded 2009 ASHP Fellow 2Health News:MHA Clinical Director Kimberly Binaso, Pharm.D. Awarded 2009 ASHP Fellow 3Health News:Beazley's New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations 2Health News:Beazley's New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations 3Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 2Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 3
(Date:12/3/2009)... , , SEATTLE and BANGALORE, ...es, a leading provider of software product and app... strategic partnership with,Microsoft BioIT Allian...s.,This will allow players in this rapidly evolvin... development capability, domain knowledge and best...
(Date:12/3/2009)... , , HELSINKI, December 3 /...,and medically proven success in their field, Ligh...cal approval to begin selecting and gene testing,s...e treatment for what the,World Health Organisation...ating and obesity. , A Phase II trial for...
(Date:12/2/2009)... , , NEW YORK, Dec. 2 /PRNewswire/...esearch report is available in its catalogue: ,...tp://www.reportlinker.com/p0164303/Arthroscopes---...opic procedures are on rise, owing to their mounti...of ankles, elbow, wrists, and hips, apart from kne...
Breaking Medicine Technology:Aditi Technologies Join Hands With Microsoft BioIT Alliance to Offer Solutions in Bioinformatics Space 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds Arthroscopes - A World Market Review 2Reportlinker Adds Arthroscopes - A World Market Review 3Reportlinker Adds Arthroscopes - A World Market Review 4Reportlinker Adds Arthroscopes - A World Market Review 5Reportlinker Adds Arthroscopes - A World Market Review 6Pennsylvania Department of Health Releases H1N1 Flu Prevention Music Video 61741 1Pennsylvania Department of Health Releases H1N1 Flu Prevention Music Video 61741 2New Reid Bill Funds Abortion 3A Excludes Bipartisan Stupak Pitts Amendment 61737 1New Reid Bill Funds Abortion 3A Excludes Bipartisan Stupak Pitts Amendment 61737 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 1Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 4
Replacement Handle
Replacement Needle Tip
Needle and Gouge Spud Set
Storz Corneal Burr
Medicine Products: